| __timestamp | Dr. Reddy's Laboratories Limited | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 91733000 |
| Thursday, January 1, 2015 | 42585000000 | 87644000 |
| Friday, January 1, 2016 | 45702000000 | 92365000 |
| Sunday, January 1, 2017 | 46372000000 | 85656000 |
| Monday, January 1, 2018 | 46910000000 | 88196000 |
| Tuesday, January 1, 2019 | 48890000000 | 89971000 |
| Wednesday, January 1, 2020 | 50129000000 | 93413000 |
| Friday, January 1, 2021 | 54559000000 | 91355000 |
| Saturday, January 1, 2022 | 62081000000 | 113676000 |
| Sunday, January 1, 2023 | 105931000000 | 198366000 |
| Monday, January 1, 2024 | 77201000000 | 218935000 |
Data in motion
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry giants: Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd., from 2014 to 2024. Over this decade, Dr. Reddy's Laboratories consistently outpaced Taro Pharmaceuticals in SG&A spending, with a peak in 2023 where their expenses were nearly 500% higher than Taro's. This trend highlights Dr. Reddy's aggressive market strategies and expansive operational scale. Notably, Taro's SG&A expenses remained relatively stable, reflecting a more conservative approach. The data underscores the contrasting business models of these companies, offering insights into their strategic priorities. As the pharmaceutical sector continues to grow, understanding these financial dynamics is crucial for stakeholders and investors alike.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Novo Nordisk A/S or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Novartis AG or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Genmab A/S or Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Dr. Reddy's Laboratories Limited
Summit Therapeutics Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Exelixis, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Galapagos NV
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.